Tia
673 Page St, San Francisco, New York, 94117, United States
Overview
Tia operates a “whole-woman, whole-life” care model that fuses primary care, gynecology, mental health and evidence-based wellness services into a single, coordinated experience delivered both virtually and in-person. Since launching in 2017, the company has grown to serve thousands of women aged 18–80 across New York City, Los Angeles, Phoenix and soon San Francisco. Tia reports strong operating metrics including a 90 Net Promoter Score average over the last two years, more than 60% of care delivered virtually, and over 50% of patients using two or more preventive care service lines; mental health is its fastest-growing service. The company also cites a diverse care team (over 50% identify as people of color) and 40% of patients identifying as people of color, while delivering roughly 40% lower cost per service than a typical primary care practice. Tia plans to use new capital to expand virtual and in-person operations, broaden service lines across the lifespan from puberty to menopause, and scale to more than 100,000 women by 2023. The model emphasizes partnerships with health systems to extend specialty access and in-network insurance offerings. Tia is a New York–based, tech-enabled women’s health company that combines brick-and-mortar services with virtual care. It offers a full continuum of services — from gynecological appointments to mental health — after originally launching as a digital health messaging service for pre- and post-care. The team expanded into physical clinics to deliver services that require in-person exams while integrating virtual capabilities for screenings and remote monitoring. During COVID-19 Tia launched its Tia Virtual Care program offering coronavirus screenings, antibody tests and remote patient monitoring. The company plans to use the $24.27M Series A to build out its virtual health capabilities and to take advantage of changed telemedicine reimbursement rules enabling commercial-payer reimbursement. Co-founder Carolyn Witte says the product is designed to address fragmentation, lack of personalization and the system’s focus on sick care versus prevention. Tia launched as an app offering health advice and a period tracker and has expanded into in-person care with its first clinic. The New York clinic, near Madison Square Park, integrates app-collected cycle and wellness data with full-stack clinical services including gynecological exams, primary care, IUD insertions, chronic migraine treatment and routine care like flu shots. Patients can share data from the Tia app with clinic physicians; the medical service does not integrate other period-tracking apps. Tia charges a $150 membership fee and accepts insurance from Aetna, Cigna, Humana, Oscar, United Oxford/United Healthcare and Empire Blue Cross Blue Shield. Founders Carolyn Witte and Felicity Yost plan to build a network of care facilities that combine digital tracking with in-person consultations and have begun clinical research to test their cycle-centered care thesis. To support that growth the company has secured $6 million in capital commitments from venture investors. Tia offers a free, personal and private women's health advisor app that provides data-driven birth control recommendations, cycle tracking, and answers to sexual health questions. The company launched the app in June and has conducted over 100,000 conversations with women since launch. The app is available for iPhone in the U.S. App Store and via askTIA.com. Tia was founded in 2016 by CEO Carolyn Witte, formerly of Google Creative Lab, and Head of Product Felicity Yost. Financially, the company has secured seed backing, most recently a $2.5m seed round reported in September 2017. The product focus is on conversational, data-driven guidance for women's sexual and reproductive health.
- Total raised
- $133M
- Funding rounds
- 4
- Latest round
- Series B
- Latest activity
- Sep 2021
Industries
- Apps
- Fitness
- Health Care
- Mental Health
- Wellness
Recent funding
Series B
Sep 2021
$100M
Series A
May 2020
$24M
Equity
Mar 2019
$6M
Seed
Sep 2017
$3M